Cyclin I is involved in the regulation of cell cycle progression

References

• Murray AW. Recycling the cell cycle: cyclins revisited. Cell 2004; 116:221 - 34; http://dx.doi.org/10.1016/S0092-8674(03)01080-8; PMID: 14744433
   PubMed Web of Science ®Google Scholar
• Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13:261 - 91; http://dx.doi.org/10.1146/annurev.cellbio.13.1.261; PMID: 9442875
   PubMed Web of Science ®Google Scholar
• Pines J. Cyclins and cyclin-dependent kinases: theme and variations. Adv Cancer Res 1995; 66:181 - 212; http://dx.doi.org/10.1016/S0065-230X(08)60254-7; PMID: 7793314
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sanokawa R, Sasaki YF, Ayusawa D, Oishi M, Mori N. Cyclin I: a new cyclin encoded by a gene isolated from human brain. Exp Cell Res 1995; 221:534 - 42; http://dx.doi.org/10.1006/excr.1995.1406; PMID: 7493655
   PubMed Web of Science ®Google Scholar
• Jensen MR, Audolfsson T, Factor VM, Thorgeirsson SS. In vivo expression and genomic organization of the mouse cyclin I gene (Ccni). Gene 2000; 256:59 - 67; http://dx.doi.org/10.1016/S0378-1119(00)00361-9; PMID: 11054536
   PubMed Web of Science ®Google Scholar
• Griffin SV, Olivier JP, Pippin JW, Roberts JM, Shankland SJ. Cyclin I protects podocytes from apoptosis. J Biol Chem 2006; 281:28048 - 57; http://dx.doi.org/10.1074/jbc.M513336200; PMID: 16847066
   PubMed Web of Science ®Google Scholar
• Hisanaga S, Endo R. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. J Neurochem 2010; 115:1309 - 21; http://dx.doi.org/10.1111/j.1471-4159.2010.07050.x; PMID: 21044075
   PubMed Web of Science ®Google Scholar
• Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 2004; 1697:143 - 53; http://dx.doi.org/10.1016/j.bbapap.2003.11.020; PMID: 15023357
   PubMed Web of Science ®Google Scholar
• Landberg G, Nilsson K, Jirström K, Rydén L, Kitching R, Burger AM, et al. Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression. Breast Cancer Res Treat 2005; 89:313 - 6; http://dx.doi.org/10.1007/s10549-004-2230-y; PMID: 15754132
   PubMed Web of Science ®Google Scholar
• Cybulski M, Jarosz B, Nowakowski A, Jeleniewicz W, Seroczyński P, Mazurek-Kociubowska M. Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer. Gynecol Oncol 2012; 127:217 - 22; http://dx.doi.org/10.1016/j.ygyno.2012.06.038; PMID: 22772062
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang MK, Cai DQ, Li M, Wong WM, Chow PH, et al. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart. Proteomics 2007; 7:23 - 32; http://dx.doi.org/10.1002/pmic.200600456; PMID: 17154274
   PubMed Web of Science ®Google Scholar
• Brinkkoetter PT, Olivier P, Wu JS, Henderson S, Krofft RD, Pippin JW, et al. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest 2009; 119:3089 - 101; http://dx.doi.org/10.1172/JCI37978; PMID: 19729834
   PubMed Web of Science ®Google Scholar
• Rechsteiner M, Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996; 21:267 - 71; PMID: 8755249
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425 - 79; http://dx.doi.org/10.1146/annurev.biochem.67.1.425; PMID: 9759494
   PubMed Web of Science ®Google Scholar
• Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6:369 - 81; http://dx.doi.org/10.1038/nrc1881; PMID: 16633365
   PubMed Web of Science ®Google Scholar
• Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008; 132:487 - 98; http://dx.doi.org/10.1016/j.cell.2007.12.033; PMID: 18267078
   PubMed Web of Science ®Google Scholar
• Nishitani H, Lygerou Z, Nishimoto T. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region. J Biol Chem 2004; 279:30807 - 16; http://dx.doi.org/10.1074/jbc.M312644200; PMID: 15138268
   PubMed Web of Science ®Google Scholar
• Piscopo DM, Hinds PW. A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1. Cancer Res 2008; 68:5581 - 90; http://dx.doi.org/10.1158/0008-5472.CAN-07-6346; PMID: 18632610
   PubMed Web of Science ®Google Scholar
• Xu G, Bernaudo S, Fu G, Lee DY, Yang BB, Peng C. Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell 2008; 19:4968 - 79; http://dx.doi.org/10.1091/mbc.E08-03-0259; PMID: 18784254
   PubMed Web of Science ®Google Scholar
• Sun ZL, Zhu Y, Wang FQ, Chen R, Peng T, Fan ZN, et al. Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim Biophys Acta 2007; 1774:764 - 71; http://dx.doi.org/10.1016/j.bbapap.2007.04.001; PMID: 17507299
   PubMed Web of Science ®Google Scholar
• Futatsugi A, Utreras E, Rudrabhatla P, Jaffe H, Pant HC, Kulkarni AB. Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons. Cell Cycle 2012; 11:1603 - 10; http://dx.doi.org/10.4161/cc.20009; PMID: 22456337
   PubMed Web of Science ®Google Scholar
• Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 2008; 105:8772 - 7; http://dx.doi.org/10.1073/pnas.0711355105; PMID: 18550843
   PubMed Web of Science ®Google Scholar
• Zhang J, Li H, Yabut O, Fitzpatrick H, D’Arcangelo G, Herrup K. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci 2010; 30:5219 - 28; http://dx.doi.org/10.1523/JNEUROSCI.5628-09.2010; PMID: 20392944
   PubMed Web of Science ®Google Scholar
• Osborn AJ, Elledge SJ, Zou L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol 2002; 12:509 - 16; http://dx.doi.org/10.1016/S0962-8924(02)02380-2; PMID: 12446112
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432:316 - 23; http://dx.doi.org/10.1038/nature03097; PMID: 15549093
   PubMed Web of Science ®Google Scholar
• Asada A, Yamamoto N, Gohda M, Saito T, Hayashi N, Hisanaga S. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J Neurochem 2008; 106:1325 - 36; http://dx.doi.org/10.1111/j.1471-4159.2008.05500.x; PMID: 18507738
   PubMed Web of Science ®Google Scholar
• Yamada M, Saito T, Sato Y, Kawai Y, Sekigawa A, Hamazumi Y, et al. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35. J Neurochem 2007; 102:1477 - 87; http://dx.doi.org/10.1111/j.1471-4159.2007.04505.x; PMID: 17394551
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Juso K, Nakano M, Nagano T, Kambayashi S, Nakashima A, et al. Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death. Cell Death Dis 2012; 3:e313; http://dx.doi.org/10.1038/cddis.2012.52; PMID: 22622132
   PubMedGoogle Scholar